
5.7.1 mRNA Vaccines, Public Health, and Safety Concerns
5.7 Health and Medical Safety
5.7.1 mRNA Vaccines, Public Health, and Safety Concerns
Recommendations
Suspend mRNA Vaccine Roll-out:
Implement an immediate moratorium on mRNA vaccines until independent safety verification is conducted.
2. Enhance Regulatory Oversight:
Establish independent bodies to monitor vaccine safety and adverse events.
Enforce stricter production standards to minimize contamination risks.
3. Improve Data Collection and Transparency:
Mandate public reporting of all adverse events and ensure VAERS data is regularly updated and accessible.
Conduct independent audits of vaccine trial data.
Mandate publication of vaccine trials data.
4. Reevaluate Vaccine Policies:
Promote informed consent by providing clear, accurate information on vaccine risks and benefits.
Develop alternative public health strategies to reduce reliance on mass vaccination.
5. Support Research and Accountability:
Fund long-term studies on the effects of mRNA vaccines.
Hold manufacturers and regulatory agencies accountable for safety violations and data omissions.
By implementing these recommendations, Canada can prioritize public safety and restore confidence in its healthcare systems.
Report Content Reader Page
đ Note to Readers
â
The content presented on this page has been adapted for online viewing and navigation. Due to formatting limitations within the web display system, certain elements—such as layout, spacing, and visual structure—may differ slightly from the original report.
â
For the complete and fully formatted version, we encourage you to download the official PDF available on the Report Information page. The PDF reflects the report exactly as it was originally written and published.



